Capital Analysts LLC’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,960
| Closed | -$642K | – | 1432 |
|
|
2024
Q4 | $642K | Hold |
1,960
| – | – | 0.03% | 303 |
|
|
2024
Q3 | $588K | Buy |
1,960
+235
| +14% | +$70.5K | 0.02% | 300 |
|
|
2024
Q2 | $568K | Hold |
1,725
| – | – | 0.03% | 311 |
|
|
2024
Q1 | $683K | Hold |
1,725
| – | – | 0.03% | 286 |
|
|
2023
Q4 | $607K | Sell |
1,725
-50
| -3% | -$17.6K | 0.03% | 293 |
|
|
2023
Q3 | $666K | Sell |
1,775
-170
| -9% | -$63.8K | 0.04% | 261 |
|
|
2023
Q2 | $744K | Hold |
1,945
| – | – | 0.04% | 251 |
|
|
2023
Q1 | $674K | Buy |
1,945
+5
| +0.3% | +$1.73K | 0.04% | 264 |
|
|
2022
Q4 | $457K | Sell |
1,940
-45
| -2% | -$10.6K | 0.03% | 309 |
|
|
2022
Q3 | $488K | Sell |
1,985
-601
| -23% | -$148K | 0.03% | 271 |
|
|
2022
Q2 | $782K | Buy |
2,586
+25
| +1% | +$7.56K | 0.05% | 231 |
|
|
2022
Q1 | $1.05M | Hold |
2,561
| – | – | 0.07% | 213 |
|
|
2021
Q4 | $1.2M | Sell |
2,561
-29
| -1% | -$13.6K | 0.07% | 202 |
|
|
2021
Q3 | $1.1M | Hold |
2,590
| – | – | 0.07% | 203 |
|
|
2021
Q2 | $929K | Buy |
2,590
+35
| +1% | +$12.6K | 0.06% | 211 |
|
|
2021
Q1 | $720K | Buy |
2,555
+635
| +33% | +$179K | 0.05% | 226 |
|
|
2020
Q4 | $544K | Buy |
1,920
+340
| +22% | +$96.3K | 0.05% | 186 |
|
|
2020
Q3 | $434K | Buy |
1,580
+165
| +12% | +$45.3K | 0.04% | 203 |
|
|
2020
Q2 | $321K | Sell |
1,415
-80
| -5% | -$18.1K | 0.03% | 202 |
|
|
2020
Q1 | $228K | Buy |
+1,495
| New | +$228K | 0.03% | 199 |
|